PP172 Recruiting Academic Physicians Without Financial Conflict Of Interest

2017 ◽  
Vol 33 (S1) ◽  
pp. 146-146
Author(s):  
Jacques Belghiti ◽  
Stéphanie Luzio ◽  
David Fuks ◽  
Gregory Emery

INTRODUCTION:To minimize the potential impact of conflicts of interest on health recommendations, several health institutions may be reluctant to recruit academic physicians due to their potential close relationship with industry. The present study aimed at evaluating the influence of academic physicians (AP) on the “rate of deport” due to financial support in the national commission of the HAS assessing medical devices.METHODS:After the renewal of this commission in November 2015, introducing patients representatives and more academic physicians, two periods of 12 months immediately before and after that date have been compared regarding the rate of deport during the sessions. Deport were decided by the legal section of our institution one week before each meeting according to a complete analysis of potential financial conflict of interest related to the medical device assessed. Only members without significant financial conflicts were allowed to participate to the discussion and the vote. The assessment of potential conflict of interest of all members followed the same criteria during the two periods.RESULTS:The number of physicians increased in the second period (nineteen versus twenty-three) with a significant higher rate of academic physicians (63 percent versus 82 percent, p = .001). The mean attendance of physicians was significantly lower during the second period (80 percent versus 65 percent, p = .03). During the two periods, the number of meetings (n = 22) was similar and the number of dossiers assessing new products was comparable (96 versus 104, p = .872). The decision to reimburse the medical devices was similar in the two periods (78 percent versus 73 percent, p = .681). The number of cases when physicians’ members were deported for conflict of interest was similar during the two periods (30 versus 28, p = .482) with not any increase among academic physicians.CONCLUSIONS:This study showed that it is possible to recruit several academic physicians without major financial conflicts of interest providing that their status could alter their assiduity.

2020 ◽  
Vol 30 (6) ◽  
pp. 1230-1232
Author(s):  
Alyssa Ralph ◽  
Mark Petticrew ◽  
Andrew Hutchings

Abstract The influence of harmful commodity industries on health research has heightened concerns around author financial conflicts of interest (FCOIs) in public health journals (PHJs), with little discussion of potential editorial, i.e., editor and reviewer, FCOIs. In this analysis of 20 prominent PHJs, detailed disclosure requirements, the inclusion of timeframes, and policy accessibility were found lacking in editorial, compared with author, FCOI policies. Disclosure forms were employed in 32% of PHJs for authors but not for editors or reviewers. Recusal policies were similar for reviewers (68%) and editors (60%). Strengthening editorial FCOI policies will increase the integrity of PHJs’ editorial processes.


2021 ◽  
Author(s):  
Jorge Roman ◽  
David J. Elpern

AbstractImportanceConflict of interest as it relates to medical education is a topic of concern. Dermatology journals, periodicals, editorials, and news magazines are influential resources that are not uniformly regulated and subject to influence from the pharmaceutical industry.ObjectiveThis study evaluates industry payments to physician editorial board members of common dermatology publications, including “throwaway” publications.DesignA list of editorial board members was compiled from a collection of clinical dermatology publications received over a 3-month period. To analyze the nature and extent of industry payments to this cohort, payments data from the Open Payments database from 2013 to 2019 were collected. Analysis of the total payments, number of transactions, categories of payments, payment sources, and physician specific characteristics was performed.ResultsTen publications were evaluated, and payments data for 466 physicians were analyzed. The total compensation across all years was $75,622,369.64. Services other than consulting, consulting, and travel/lodging payments comprised most of the payments. A faction of dermatologists received the majority of payments. The top payers were manufacturers of biologic medications. Payment amounts were higher for throwaway publications compared to peer-reviewed journals.ConclusionsEditorial board members of dermatology publications received substantial payments from the pharmaceutical industry. A minority of physicians receive the lion’s share of payments from industry. “Throwaway” publications have more financial conflict of interest than peer-reviewed journals. The impact of these conflicts of interest on patient care, physicians practice patterns, and patient perception of physicians is noteworthy.


Blood ◽  
2009 ◽  
Vol 114 (22) ◽  
pp. 810-810
Author(s):  
Sekwon Jang ◽  
Young Kwang Chae ◽  
Navneet S. Majhail

Abstract Abstract 810 Economic analyses of pharmaceutical agents are important determinants of health reimbursement decisions and are essential components of comparative effectiveness research. The American Society of Hematology (ASH) annual meeting is an important forum for presentation of economic analyses of hematology-oncology drugs. We hypothesized that economic analyses sponsored by pharmaceutical companies would be more likely to support that company's product. We conducted this study to determine the frequency of financial conflicts of interest in economic analyses presented at the ASH annual meeting and to examine whether such conflicts influenced study outcomes and directly or indirectly supported a specific product (an example of indirect support is a study on costs of febrile neutropenia sponsored by a pharmaceutical company that manufactures granulocyte colony-stimulating factor). ASH annual meeting abstracts from 2006-2008 were searched for economic analyses using following search terms: ‘cost', ‘economic', ‘dollar', ‘cost-effective', and ‘cost-benefit'. All abstracts in the ‘Health Services and Outcomes Research' category were also reviewed for economic analyses. Information was collected on the type of economic analysis, health technology assessed, author affiliation, the presence of conflict of interest and study conclusion. A total of 124 original economic analyses were identified. The majority of studies (52%) were conducted in the US, followed by Canada (11%) and UK (7%). Most studies were presented as a poster (61%). Eighty-seven studies (70%) evaluated a pharmaceutical product. First author affiliations included academic institutions (67%), consulting company employee (23%) and employee of sponsoring corporate (10%). Eighty-eight of 124 studies (71%) had at least one author with a financial conflict of interest. Studies with a conflict of interest were more likely to evaluate a pharmaceutical product than studies without a conflict of interest (81% vs. 44%, p<0.001). First authors of abstracts with a conflict of interest were less likely to be affiliated with an academic institution compared with abstracts without a conflict of interest (53% vs. 100%, p<0.001). The conclusions of 87 of 88 economic analyses with a conflict of interest favored the sponsor's product either directly (72%) or indirectly (27%). In conclusion, financial conflicts of interest are common in economic analyses presented at the ASH annual meeting. Almost all economic analyses with a financial conflict of interest support their sponsor's products. We could not exclude a publication bias, wherein economic analyses that did not favor a sponsor's product were less likely to be submitted for presentation. Economic analyses have important health policy implications and conflicts of interest should be carefully considered when interpreting the conclusions of economic analyses. Disclosures: No relevant conflicts of interest to declare.


2021 ◽  
Vol 49 (2) ◽  
pp. 57-62
Author(s):  
Dmytrychenko-Kuleba G ◽  

To date, the study of such categories as conflict of interest, real conflict of interest, potential conflict of interest is important in the field of public administration. After all, the work of the subjects of power in a real or potential conflict of interest interferes with the work of the enterprise, institution, organization. This negatively affects the efficiency, effectiveness of public administration, leads to negative economic and legal consequences. The object of research is the prevention and settlement of conflicts of interest. The purpose of the work is to analyze ways to prevent and resolve conflicts of interest. Research method – method of comparison, method of analysis. KEYWORDS: CONFLICT OF INTERESTS, REAL CONFLICT OF INTERESTS, POTENTIAL CONFLICT OF INTERESTS, PUBLIC GOVERNANCE.


2013 ◽  
Author(s):  
◽  
Steven Douglas Buist

Ethical behaviour by investigators is the cornerstone of scientific research. Recognizing, declaring and avoiding a conflict of interest are key responsibilities for biomedical researchers, particularly since commercial enterprises, such as pharmaceutical companies, have become major funding sources of research. Proactive disclosure of researchers' financial relationships is now a requirement for publication in most scientific journals. The question that arises is whether this same increased scrutiny of financial disclosure and potential for conflict of interest has extended to the mainstream press in Canada. A content analysis of biomedical research articles that appeared in Canadian daily newspapers from 2001 to 2008 showed that 82 per cent of the articles failed to identify the financial connection that existed between the researcher(s) and the commercial funder, and nearly half of the articles did not even identify the commercial funding source of the research. A text analysis showed that 94 per cent of the articles were positive about the drug/device cited by the research, and positive, optimistic words such as “breakthrough”, “significant”, “hope” and “promising” were often used in the news articles. Reporters frequently frame biomedical research articles using a battle-like template that describes a fight between good and evil. Another common approach was to frame the article as a message of hope for the future. A genre analysis showed that the genre of medical research news articles published in newspapers is highly dissimilar to the genre of medical research articles published in scientific journals. It is likely these two genres have been constructed to appeal to very different target audiences. The study results show overwhelmingly that readers are not provided with key information about potential financial conflicts of interest involving the researchers and the commercial sources of funding for the research. Such lack of transparency thwarts the reader’s ability to reach informed conclusions about whether or not the research has been either explicitly or implicitly influenced by the researcher’s potential conflict.


2020 ◽  
Vol 26 (2) ◽  
pp. 145-149
Author(s):  
Aurelia Teodora Drăghici

SummaryTheme conflicts of interest is one of the major reasons for concern local government, regional and central administrative and criminal legal implications aiming to uphold the integrity and decisions objectively. Also, most obviously, conflicts of interest occur at the national level where political stakes are usually highest, one of the determining factors of this segment being the changing role of the state itself, which creates opportunities for individual gain through its transformations.


Author(s):  
Katherine Severi

Ralston et al present an analysis of policy actor responses to a draft World Health Organization (WHO) tool to prevent and manage conflicts of interest (COI) in nutrition policy. While the Ralston et al study is focussed explicitly on food and nutrition, the issues and concepts addressed are relevant also to alcohol policy debates and present an important opportunity for shared learning across unhealthy commodity industries in order to protect and improve population health. This commentary addresses the importance of understanding how alcohol policy actors – especially decision-makers – perceive COI in relation to alcohol industry engagement in policy. A better understanding of such perceptions may help to inform the development of guidelines to identify, manage and protect against risks associated with COI in alcohol policy.


2021 ◽  
pp. 0272989X2110088
Author(s):  
Rachel Thompson ◽  
Zoe Paskins ◽  
Barry G. Main ◽  
Thaddeus Mason Pope ◽  
Evelyn C. Y. Chan ◽  
...  

Background More stringent policies for addressing conflicts of interest have been implemented around the world in recent years. Considering the value of revisiting conflict of interest quality standards set by the International Patient Decision Aid Standards (IPDAS) Collaboration, we sought to review evidence relevant to 2 questions: 1) What are the effects of different strategies for managing conflicts of interest? and 2) What are patients’ perspectives on conflicts of interest? Methods We conducted a narrative review of English-language articles and abstracts from 2010 to 2019 that reported relevant quantitative or qualitative research. Results Of 1743 articles and 118 abstracts identified, 41 articles and 2 abstracts were included. Most evidence on the effects of conflict of interest management strategies pertained only to subsequent compliance with the management strategy. This evidence highlighted substantial noncompliance with prevailing requirements. Evidence on patient perspectives on conflicts of interest offered several insights, including the existence of diverse views on the acceptability of conflicts of interest, the salience of conflict of interest type and monetary value to patients, and the possibility that conflict of interest disclosure could have unintended effects. We identified no published research on the effects of IPDAS Collaboration conflict of interest quality standards on patient decision making or outcomes. Limitations Because we did not conduct a systematic review, we may have missed some evidence relevant to our review questions. In addition, our team did not include patient partners. Conclusions The findings of this review have implications for the management of conflicts of interest not only in patient decision aid development but also in clinical practice guideline development, health and medical research reporting, and health care delivery.


1982 ◽  
Vol 31 (3-4) ◽  
pp. 157-163 ◽  
Author(s):  
Marie-Françoise Desgranges ◽  
Xavier De Muylder ◽  
Jean-Marie Moutquin ◽  
Francisco Lazaro-Lopez ◽  
Bernard Leduc

Four hundred and thirty four twins occurring in 220 women were studied during a period of 11 years (1969–1979) at Notre-Dame Hospital.Perinatal mortality (< 28 days) was compared before and after 1974, and the impact of ultrasound technique upon perinatal outcome was assessed during the second period (1974–1979). The main factor associated with perinatal mortality was low birth weight caused by either prematurity or intrauterine growth retardation.While fetal mortality remained unchanged within the two study periods, neonatal mortality decreased from 68.2/1,000 to 28.9/1,000 mainly due to increased survival rate of twins below 1,500 g at birth.With identical perinatal care during the same period, perinatal mortality and incidence of intrauterine growth-retarded twins remained unchanged despite early diagnosis by ultrasound.


Sign in / Sign up

Export Citation Format

Share Document